Acute Leukemia of Ambiguous Lineage — Trials

Acute Leukemia of Ambiguous Lineage — Trials · CancerIndex

Clinical trials

Registered studies

139 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 65
Recruiting: 38
Ph III recruiting: 2
Growth YoY: —
Industry share: 14%
Top sponsor: Fred Hutchinson Cancer Center
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (20)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00557193	Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	completed	Phase 3	218	Children's Oncology GroupNETWORK	4	Jul 15, 2024	clinicaltrials
NCT01951885	Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention	completed	Phase 3	101	Case Comprehensive Cancer CenterOTHER	1	Sep 11, 2023	clinicaltrials